Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Monitor Mondays Marks 10th Anniversary of Inaugural Broadcast


Monitor Mondays Live Podcast Logo

Monitor Mondays has become an indispensable source of information for healthcare providers of many different types

Monitor Mondays, the weekly live podcast produced by RACmonitor.com, is marking the 10th anniversary of its inaugural edition with an extended hour-long live podcast, it’s first of the new calendar year, at 9 a.m. CST on Monday, January 13.

“RACmonitor was launched in 2008 because, at that time, the Recovery Audit Contractor (RAC) program was gaining traction. The Centers for Medicare & Medicaid Services (CMS) had recently concluded a demonstration (pilot) of the RAC concept with four states, and the consensus was that CMS would move forward, and so we wanted to alert hospitals to this new development,” RACmonitor.com Publisher and Monitor Mondays Program Host and Executive Producer Chuck Buck recalled. “The federal auditing that began at that point has only intensified ever since, and Monitor Mondays quickly became a landmark, go-to feature that helps us keep readers and listeners informed.”

Nearly 12,400 professionals from across the U.S. healthcare system subscribe and listen in to Monitor Mondays each week – more than two listeners for each of the estimated 5,500-6,000 hospitals currently operating nationwide. Of those listeners, as many as 1,000 tend to tune in live each Monday morning, and far more take in the recorded podcast, which from 2018 into 2019 boasted more than 250,000 replays across the various streaming platforms that now offer it – including Spotify, iTunes, Google Play, TuneIn, and Stitcher.

“As a new decade begins, it will be more important than ever for compliance practitioners to stay informed and engaged. The interest in healthcare coordination and accountability to secure value-based, positive health outcomes will only accelerate in the future, with the introduction of new technological tools and additional scientific discoveries. Compliance officials will play a critical role in ensuring that their providers maintain sound compliance practices as new delivery and payment designs are implemented to meet these new expectations,” said former U.S. Department of Health and Human Services Inspector General Daniel Levinson, who resigned last year after serving 15 years in that capacity. “As the compliance mission becomes more central to enterprise success, having the right information-gathering and networking opportunities are critical. Through its weekly broadcasts, RACmonitor provides a highly efficient and timely service, precisely to meet these ever-growing needs.”

Levinson was one of 10 healthcare industry experts to record testimonials about the 10th anniversary of Monitor Mondays’ launch – some of which will be shared during the special hour-long live podcast.

“Monitor Mondays has become an indispensable source of information for healthcare providers of many different types,” said William A. Dombi, Esq., President of the National Association for Home Care & Hospice. “I’m privileged to be part of the Monitor Mondays team, and really look forward to another 10 years of great, timely information that covers the topics that are so essential to making healthcare as significant a part of society as it is.”

Monitor Mondays has been recognized for excellence in reporting by numerous individuals and organizations over the years, most recently when ExamWorks listed it among its “50 Best Podcasts for Claims Adjusters” in June 2019.

Looking to the future, Buck pledged that professionals from every corner of the healthcare industry will be able to continue to rely on the website and the podcasts to stay at the vanguard of every relevant change that comes along – which, if the last few years are any indication, are sure to be many.

“RACmonitor and Monitor Mondays will continue to be the single most important source of regulatory and audit news and information,” Buck said. “Both entities will continue to focus on the interaction of the federal government with healthcare providers – provider settings in acute care, ambulatory surgical centers (ASCs), and rural health, as well as behavioral health, including the social determinants of health.”

To to listen to Monitor Mondays and register to listen live every monday, visit https://www.racmonitor.com/monitor-mondays-podcasts or search for Monitor Mondays on any of the aforementioned podcast streaming services.

RACmonitor, a division of MedLearn Media, Inc., is an online news and information source produced to help healthcare providers make informed decisions for their organizations on the activities of third-party contract auditors, such as the Recovery Audit Contractors and governmental auditors such as those with the Office of Inspector General (OIG) within the U.S. Department of Health and Human Services (HHS). RACmonitor offerings for subscribers include:


  • Weekly eNewsletters covering hot topics on regulatory compliance
  • A weekly live podcast (Monitor Mondays)
  • Live webcasts featuring nationally recognized thought leaders
  • Special bulletins and news alerts
  • Notifications of upcoming webcasts and special programs
  • Up-to-date resources at RACUniversity

RACmonitor, along with its family of brands, including ICD10monitor and MedLearn Publishing, are trusted sources of news and information provided under their parent company name, MedLearn Media Inc.

MedLearn Media, Inc. provides trusted expertise to the healthcare industry in the areas of coding, compliance, reimbursement, and regulatory changes. It offers a family of leading brands on multimedia publishing platforms, including print and digital books, visual charts, newsletters, webcasts, seminars, on-demand content, and more. MedLearn Media, Inc. continues to build on a nearly 30-year legacy of trust, reliability, and peace of mind, and it remains a company that customers can depend on. The company is based in St. Paul, Minn. More information can be found online at http://www.medlearnmedia.com.

Share article on social media or email:

BayMark Health Services Opioid Treatment Programs Nationwide Now Accept Medicare


“We are extremely pleased that Congress has included Medicare coverage of OTPs in the just-passed opioid package,” said Jason Kletter, PhD, president of BayMark Health Services.

BayMark Health Services has announced that they are now able to accept Medicare for medication-assisted treatment services at their Opioid Treatment Programs (OTPs) across the country. Coverage for treatment with methadone, buprenorphine and naltrexone, all FDA-approved medications, as well as counseling, began on January 1st. All BayMark branded opioid treatment programs are eligible, including BAART Programs, Health Care Resource Centers, MedMark Treatment Centers and Recovery Services of New Mexico, with the exception of our newest programs who have not yet obtained their CARF-accreditation.

The October 24, 2019 signing of opioid bill H.R. 6, referred to as The SUPPORT for Patients and Communities Act, extended this benefit for Medicare subscribers who may have otherwise lost their ability to stay in treatment when they switched from Medicaid to Medicare or for whom treatment was cost-prohibitive when not covered by their Medicare plan.

“We are extremely pleased that Congress has included Medicare coverage of OTPs in the just-passed opioid package,” said Jason Kletter, PhD, president of BayMark Health Services. “This coverage will, once implemented, provide immediate benefit to the roughly 20,000 Medicare beneficiaries currently receiving treatment in OTPs, as well as create treatment access for the 300,000 beneficiaries with a diagnosis of opioid use disorder,” Dr. Kletter told AT Forum. “In addition, Medicare coverage will likely result in greater coverage of OTP services by commercial health plans, exponentially increasing access to high quality, evidence-based MAT across the country.”

BayMark branded OTPs are known across the country as providers of quality, comprehensive medication-assisted treatment and counseling services. Programs provide addiction education, relapse prevention, lab testing, coordinated care for pregnant patients and linkages to community resources to assist patients on their path to recovery. The BayMark mission is to provide comprehensive medication-assisted treatment for opioid use disorder and other health care services to foster wellness, longevity and socially responsible behavior for the patients we serve.

“BayMark, through our various brands, provides treatment for opioid use disorder. We attempt to match each patient with the best level of care for their individual needs,” shared David K. White, Ph.D., CEO of BayMark Health Services. “Historically, methadone treatment has proven to be the most effective approach to providing affected individuals a real opportunity to recover, in part due to the structure of the OTP. It is great progress for our country that Medicare will now cover methadone treatment, as well as buprenorphine and naltrexone treatment, in the OTP setting. BayMark is happy to be a part of the solution to the opioid epidemic and all initiatives increasing accessibility and affordability of treatment.”

To find a BayMark OTP location near you, visit: http://www.Baymark.com/treatment-locations/.

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to more than 56,000 patients in recovery from substance use disorder across the United States and Ontario, Canada. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of opioids, alcohol and other prescription and illicit substances. The BayMark continuum of patient-focused services includes: highly structured opioid treatment programs utilizing methadone or buprenorphine and outpatient buprenorphine treatment programs, both of which incorporate counseling as part of an individualized treatment plan for opioid use disorder. Additionally, ambulatory withdrawal management services with naltrexone therapy, and inpatient detoxification services are offered for a variety of substance use disorders.

Share article on social media or email:

1-800-PetMeds® To Sponsor Danny & Ron’s Rescue at Winter Equestrian Festival


It takes a big family to care for the hundreds of animals that come to our rescue every year and 1-800-PetMeds is part of that family.

In an effort to rescue and care for dogs in need and help them find their forever homes, 1-800-PetMeds® is teaming up with Danny & Ron’s Rescue by sponsoring their adoption booth at the 2020 Winter Equestrian Festival.

All adoptable dogs will be spayed or neutered, up to date on shots, microchipped, and ready to go to their new families. The rescue does not charge a set adoption fee, instead relying on generous donations from members of the equestrian community, sponsors, and supporters to provide essential medical care to every dog before adoption.

To overcome emotional and behavioral issues and to transition from abusive and neglectful situations, adoptable dogs reside with founders Danny Robertshaw and Ron Danta and up to 75 other dogs at the founders’ South Carolina home, on their nearby farm, and in foster homes. There, they are given round-the-clock care, love, and attention with the help of staff and volunteers.

“It takes a big family to care for the hundreds of animals that come to our rescue every year and 1-800-PetMeds is part of that family,” says Kim Tudor, Director of Marketing and Adoption at Danny & Ron’s Rescue. “They make sure that we have all the medications and supplements we need at any given time for our dogs and horses. That’s what peace of mind is all about; knowing 1-800-PetMeds is there for our animals.”

“Danny & Ron’s Rescue gives dogs the emotional support they need after having been abused and abandoned. We love seeing how their dogs are not only physically healthier after they’re rescued, but also how they learn to love and trust before going on to their forever homes. We’re so proud to help make that possible,” says Larissa Schenck, Director of Marketing at 1-800-PetMeds®.

About 1-800-PetMeds®

Founded in 1996, Petmeds.com is America’s Most Trusted Pet Pharmacy® providing fast, easy and helpful service to over ten million customers across the U.S. by delivering prescription and non-prescription medications and pet supplies for less, direct to the consumer through its 1-800-PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the 1-800-PetMeds® mobile app available for free at Google Play for Android and the App Store for iOS.

About Danny & Ron’s Rescue

Danny & Ron’s Rescue, showcased in the 2018 Netflix documentary “Living in the Doghouse,” has rescued over 10,000 dogs since 2005. Founders Danny Robertshaw and Ron Danta, who are also full-time horse trainers, turned their own house into the ultimate safe haven where they personally care for up to 75 injured and abused animals at a time until they are ready for adoption. Each dog receives a wellness check from their veterinarian, is then spayed/neutered, vaccinated, microchipped, dewormed, groomed, and loved. They are also proud to be one of the only organizations that does not charge a pre-set adoption fee and instead relies on an affordable donation from the adopter.

About Winter Equestrian Festival

The Winter Equestrian Festival (WEF) is the largest and longest-running equestrian competition in the world. It lasts 12 weeks from January through March in Wellington, a village right next to West Palm Beach, Florida. Each week, the festival features its own horse show and competitions. There are also a few competitions that continue throughout the whole 12 weeks of the festival.

Share article on social media or email:

Shady Grove Fertility (SGF) New York Announces Nine Upcoming Patient Education Events in its New Manhattan Location, Hosted by Drs. Anate Brauer and Tomer Singer


Drs. Anate Brauer and Tomer Singer of SGF New York to host nine patient education events in January, February and March 2020.

SGF’s newest full-service location in Manhattan offers access to two leading, board certified reproductive endocrinologists—Drs. Anate Brauer and Tomer Singer—a state-of-the-art laboratory, and an indisputable track record of success.

Physicians from Shady Grove Fertility (SGF) New York will host nine free educational events this January, February, and March, including three fertility seminars, three donor egg treatment seminars, and three egg freezing seminars.

Attendees can unwind with refreshments during informal, physician-led seminars and question-and-answer sessions with leading experts in infertility.

SGF New York’s fertility seminars will cover infertility basics, including menstrual cycle warning signs, common causes of infertility, how infertility is diagnosed and recommendations for when to see a fertility specialist, success rates, financial programs, treatment options, and much more. SGF New York’s fertility seminars are free and include a complimentary physician consult that can be scheduled onsite.

SGF New York’s donor egg treatment seminars will provide in-depth look into SGF’s internationally renowned Donor Egg Treatment Program, the largest program in the nation. SGF, home to more than 8,000 babies born from donor egg treatment, is one of only a few centers in the nation that recruits, selects, and prescreens (medically, psychologically, and genetically) its own ready-to-cycle egg donors prior to making them available on their donor registry. Further, SGF offers exclusive 100% refund guarantee programs not only for IVF but donor egg treatment—a significant differentiator among other programs in the area. All attendees will receive a complimentary physician consult and one lucky attendee will receive $1,000 off a future donor egg treatment at SGF New York.

SGF New York’s egg freezing seminars will offer attendees a deep dive into SGF’s track record with egg freezing, a fertility-preserving option that’s growing in popularity at an unprecedented 20 percent per year, nationally, with even higher growth rates in New York City and surrounding areas. SGF holds the spot as one of the top five egg freezing programs in the U.S., and the number of women choosing egg freezing at SGF continues to rise. The seminar will cover SGF’s success rates, with SGF being one of only a few centers in the nation with published success rates for women who return to use their frozen eggs. In addition, the seminar will cover what to expect during fertility testing to determine candidacy for egg freezing, what to expect during an egg freezing cycle, financial programs, SGF’s refund guarantees for egg freezing, and much more. All attendees will be entered into a raffle where one lucky attendee will receive $1,000 off a future egg freezing treatment cycle at SGF New York.

All SGF New York seminars will be hosted in their new 15,300 square foot space in New York City, conveniently located at 110 East 60th Street—minutes from nine NY subway stations providing easy access from all boroughs as well as Westchester, Long Island, and Connecticut, and steps from Bloomingdales, Rockefeller Center, Central Park, and The Plaza Hotel.

The SGF New York location is home to physician offices for patient consultations, SGF’s ninth embryology lab, a spacious operating room, embryo transfer room, and recovery bays. Patients benefit from having an onsite dedicated andrology laboratory for sperm preparation and an onsite endocrinology lab for processing bloodwork.

Services available in SGF New York include fertility testing and diagnosis, including semen analysis; non-invasive fertility options such as ovulation induction and intrauterine insemination (IUI); in vitro fertilization (IVF); donor egg treatment; preimplantation genetic testing; fertility preservation through egg freezing; and LGBTQ family building.

Fertility Seminars

January 14 | What to Expect When You’re Not Expecting | Dr. Tomer Singer

February 6 | What to Expect When You’re Not Expecting | Dr. Anate Brauer

March 5 | What to Expect When You’re Not Expecting | Dr. Anate Brauer

Donor Egg Treatment Seminars

January 23 | Donor Egg Treatment | Dr. Anate Brauer

February 13 | Donor Egg Treatment | Dr. Tomer Singer

March 19 | Donor Egg Treatment | Dr. Anate Brauer

Egg Freezing Seminars

January 16 | Egg Freezing | Dr. Anate Brauer

February 24 | Egg Freezing & Endometriosis | Drs. Brauer & Singer, with guest speaker Dr. Seckin

March 26 | Egg Freezing | Dr. Tomer Singer

While all SGF in-person and online events are complimentary, interested parties must register to attend by visiting the SGF calendar of events.

Dr. Anate Brauer earned her medical degree from the George Washington University School of Medicine. She completed her residency training in obstetrics and gynecology at New York Presbyterian Hospital-Weill Cornell Medical Center, and her fellowship training in reproductive endocrinology and infertility at Weill Cornell Medical College in New York, NY. Dr. Brauer is board certified in obstetrics and gynecology and reproductive endocrinology and infertility.

Dr. Singer earned his medical degree from the Sackler School of Medicine and his Master of Business Administration in Health Care Management from Hofstra Zarb School of Business. He completed his residency training in obstetrics and gynecology at Lenox Hill Hospital in New York, NY, where he also served as Chief Resident, and his fellowship training in reproductive endocrinology and infertility fellowship at Weill Cornell Medical College in New York, NY. Dr. Singer is board certified in obstetrics and gynecology and reproductive endocrinology and infertility.

To make an appointment in New York City, call 212-203-4826 or submit this brief form.

To schedule an appointment at any of SGF’s other 35 domestic locations, call the SGF New Patient Center at 888-761-1967.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 36 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

NeoTract Designates Dr. Andrew Maes as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Andrew Maes as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Andrew Maes, DO, ThedaCare in Berlin, WI, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Maes has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Andrew Maes as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Patient Loyalty Is Now a Strategic Imperative for Healthcare Providers – Industry Analysis by Loyale Healthcare


Loyal patients lead to better hospital outcomes but poor financial experiences threaten relationships and revenue

Most healthcare providers are damaging their brands’ potential by delivering financial care that doesn’t measure up to their clinical care. Put plainly, these providers are putting revenue at risk. – Kevin Fleming, CEO, Loyale Healthcare

Every business hopes its customers will be loyal. Loyal customers return for future purchases. They refer their friends and family. And they’re usually more forgiving when the inevitable problem comes up. In some industries, loyalty can suppress the consumer’s urge to look elsewhere, even when there are less expensive alternatives. Any way you look at it, a loyal customer is one of any organization’s most valuable assets.

The same is true for hospitals and the healthcare industry. But unfortunately for some providers, patient loyalty has never been more at risk. As consumer out-of-pocket costs for premiums, deductibles, co-pays and care itself have reached record highs, patients (especially Millennials, Gen Xers and younger) are giving up on the old Primary Care Physician model of care delivery and looking for better value and convenience.

One of the biggest sources of patient/consumer frustration is related to their financial experiences, especially the lack of price transparency and the financial planning made possible by that transparency. For patients, cost is a big deal. So big in fact, that as many as half of Americans have reported avoiding or delaying care because of concerns about their ability to afford it. Those who do pursue care are more likely to abandon treatment or to neglect paying.

These observations were confirmed recently by a survey conducted by Access One, a healthcare finance company, to measure provider loyalty. Responding to the survey, more than 1,000 healthcare consumers said that:


  • 40% of were unsure how they would pay for an unexpected medical expense under $500
  • 60% said an unexpected medical bill of less than $1,000 would spark worry
  • 22% said even $250 would prompt financial stress

The survey also explored patients’ experiences figuring out how to pay for the care they have received. Here, survey respondents answered that:

  • 20% don’t understand their options for paying for medical procedures or other healthcare expenses
  • Just 27% are very satisfied with their options for payment
  • 74% say that their providers have not spoken with them regarding patient financing options or the availability of a payment plan in the last two years

Most significant for this analysis, respondents to the survey demonstrate a willingness to switch providers to find a more satisfying financial experience.

  • 40% of respondents would switch providers to access affordable payment arrangements, including half of households with children
  • 75% are willing to shop around for care based on price (38% already are)
  • 81% are most likely to want to discuss financing/payment plans with their provider (any generation)
  • Though baby boomers are least likely to consider switching, 71% want to discuss their ability to pay with their physician

We’ve written before about the persistent gap between the quality of a patient’s clinical experience and their financial experience. The results of this survey underscore the financial and operational risks that this gap represents. To us, the message is loud and clear, hospitals can no longer afford to deliver sub-standard experiences in any dimension of the patient’s journey – whether clinical, administrative or financial.

Calculating the value of loyalty

With patient relationships at greater risk than ever before, winning and retaining patients is critical for providers that intend to compete and prosper in today’s increasingly consumer-driven marketplace. Patient retention – or loyalty – has become one of a hospital’s most valuable financial indicators, so it’s important to know how much each one of those relationships is worth.

One of the most straightforward ways to measure the value of a patient’s loyalty is to calculate the average lifetime value of a patient relationship. The formula is a simple one: V x N x Y, where V = the average value of a billable patient encounters in any given patient population, N = the average number of encounters per year and Y= the average number of years the patient will visit the hospital. The calculation can be refined by segmentation and/or multipliers to account for the patient’s influence on other patients.

Simplified even further, it’s possible to calculate a rough estimate using the Centers for Medicare & Medicaid Services’ (CMS) Net Healthcare Expenditure for 2018 figure of $11,172 per person.

  • Let’s say 50%, or of this per-person expenditure represents a patient’s billable encounters with a hospital in a year, representing $5,586 in provider revenue. Please note: The revenue source (payer) is irrelevant because patient choice drives the revenue, not the relationship between the payer (insurance company) and the provider.
  • Average annual per-patient hospital expenditure per year of $5,586 is multiplied by the average number of years the patient is expected to return to the provider, in this case 25
  • Yields a Lifetime Patient Value of $139,650, which accounting for inflation of 2.1% over the lifetime of the patient relationship becomes $177,644 in hospital revenue directly attributable to each patient based on the behavior of the average patient.

This is of course a crude over-simplification, but it illustrates how any provider can use its own patient encounter and financial data to determine its own lifetime patient value. Hospitals may also have the ability to calculate the multiplier effect that loyal patients can have on patient acquisition. One analysis suggests that a patient’s total lifetime value is more than $600,000.

Using this calculation and the patient survey results cited above, providers must consider the impact of patient attrition in an increasingly competitive marketplace. If 40% of patients are willing to switch providers to access more affordable payment arrangements, how much revenue is at risk?

On the other hand, the upside opportunity for providers that step up to meet patients’ expectations are tremendous. Here, innovative providers have the enviable opportunity to project the longer-term impacts if they are able to lure away 40% of their competitors’ patients by offering more consumer-friendly financial experiences.

In our experience helping healthcare providers attract and retain more patients, “consumer-friendly” financial experiences are characterized by a number of attributes, up to and including:

1. Single-platform communications between physician/practice and patient, including financial information pertinent to the patient’s care and treatment throughout their care journey

2. Price transparency before treatment begins, with estimations for the total cost of care as well as the patient’s portion for payment

3. Payment plan options to assist patients whose financial circumstances do not allow for full payment when due

4. Investments in lower-cost care delivery channels, such as telehealth and/or urgent care facilities that offer lower costs, greater convenience and improved accessibility for non-emergent patients

5. Personalized wellness programs and content, leveraging patient data to inform ongoing patient communications to optimize health outcomes

Why a healthcare provider’s brand matters more now than ever

At its highest level, a “brand” is defined as the emotional and psychological associations that a person (patient) or market makes with a hospital or healthcare system. Strong brands enjoy greater customer loyalty, better financial performance and higher valuations. But, as this analysis and the survey results above illustrate, most healthcare providers are damaging their brands’ potential by delivering financial care that doesn’t measure up to the high standards associated with their clinical care. Put plainly, these providers are putting revenue at risk.

At Loyale Healthcare, we’re proud to have been chosen as the patient financial engagement platform for HCA Healthcare, recently recognized as one of healthcare’s most valuable brands by BrandFinance. Working together with HCA and other healthcare enterprises across the country, we’re bridging the gap between what patients expect and what they get in their financial dealings with their providers. With upfront price transparency; personalized, data-driven financial plans; patient financing; responsive digital patient communications and the industry’s most robust patient financial portal, we’re helping healthcare providers meet their patients’ – and their markets’ – highest expectations for financial care.

Our company was founded on the principle that fiercely loyal patients are indeed a provider’s most valuable asset. Our founder, Dan Peterson, was among the first to recognize the disruption that consumerism would inevitably bring to healthcare, so Loyale was developed to help providers compete and grow – with a platform designed from the ground up to complement and integrate healthcare providers’ existing technologies to enable the delivery of comprehensive, holistic care.

By bringing the entire patient journey into view for patients and providers, we’re helping companies like HCA Healthcare burnish their brands, build patient loyalty and improve financial performance. Based on the responses of patients, it appears we’re on the right track.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale recently announced an enterprise level strategic partnership with Parallon including deployment of its industry leading technology to all HCA hospitals and Physician Groups.

The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Increasing complexities often force study teams to start looking for multi-vendor approaches

There’s a lot of discussion around the benefits of a unified platform, or one-stop-shop for eClinical solutions (Electronic Data Capture [EDC], Interactive Response Technology [IRT], eConsent, electronic Patient-Reported Outcomes [ePRO], etc.). While a single platform may satisfy the needs of smaller studies, what happens when your studies become larger and your protocols become more complex? Increasing complexities often force study teams to start looking for multi-vendor approaches.

On Thursday, January 23, 2020 at 11am EST (4pm GMT/UK), three expert panelists will lead a live session where they will discuss:


  • How a harmonized IRT & EDC integration can transform clinical trial execution
  • The benefits of utilizing two best-of-breed eClinical software solutions (pros and cons of the multi-vendor approach)
  • How to optimize workflow and streamline patient randomization and drug supply management to support complex studies

The featured speakers include:

  • Scott Dixon, Global Vice President, Strategic Partnerships, Suvoda
  • Drew Garty, Chief Technology Officer, CDMS, Veeva Systems
  • Catherine Munera, PhD, Head of Biometrics, Cara Therapeutics

Catherine Munera from Cara Therapeutics will discuss the benefits the company has seen in their studies by moving from a single provider to a harmonized, best-of-breed approach. The webinar will also include other examples illustrating both Suvoda and Veeva support patient cohort branching, treatment cycles and system integrations.

For more information or to register for this event, visit The Benefits of a Seamless IRT and EDC Integration in Clinical Trial Execution.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Royal Biologics announces the launch of MAGNUS, a DMSO-free viable cellular bone allograft


Royal Biologics MAGNUS Viable Cellular Allograft

“MAGNUS presents a novel product class opportunity in orthopedics. We feel that the industry was calling for a DMSO-free viable graft solution and MAGNUS meets that demand.” – Salvatore Leo, CEO

Royal Biologics, an ortho-biologics company specializing in the research and advancement of regenerative cellular therapy and novel orthobiologic solutions, has announced the launch of MAGNUS, a DMSO-free viable cellular bone allograft. MAGNUS presents a unique solution to traditional viable cellular allograft technology as it utilizes a DMSO-free cryoprotectant. This novel approach to the viable cellular allograft market differentiates MAGNUS from all other technologies currently available.

Proper preservation of cellular allografts requires strict adherence to recovery and processing protocols. In the MAGNUS viable cellular bone allograft, viable spine-derived cells are collected from the vertebral body region of the donor and preserved with the use of a DMSO-free cryoprotectant.

“We are very excited to add MAGNUS to our portfolio of novel orthobiologic solutions for fusion in orthopedics,” says Salvatore Leo, Chief Executive Officer of Royal Biologics. “MAGNUS presents a new class of viable cellular allografts which we feel present the surgeon with favorable options for bone graft based procedures.”

In a recently published peer-reviewed study looking at 75 consecutive cases with 12 months of follow up, MIS TLIF Fusion with MAGNUS Viable Allograft demonstrated a 96% fusion rate of the 75 patients with a total of 85 levels achieving fusion at 12 months.1

“MAGNUS presents a novel product class opportunity in orthopedics. We feel that the industry was calling for a DMSO-free viable graft solution and MAGNUS meets that demand.”

For more information on MAGNUS, MAXX-CELL, and Royal Biologics please visit http://www.royalbiologics.com

1. Tally, William C, et al., Transforaminal Lumbar Interbody Fusion with Viable Allograft: 75 Consecutive Cases at 12-Month Follow-Up. International Journal of Spine Surgery, 2018. Vol. 12, No. 1 pp 76-84.

Share article on social media or email:

Northern Westchester Hospital names new chief nursing officer


“Catherine Manley-Cullen is a dynamic, progressive leader with a wide range of professional experience and a commitment to delivering compassionate care to culturally diverse populations,” says Derek Anderson, executive director of NWH.

Catherine Manley-Cullen, MS, RN, NEA-BC, an accomplished health care leader with more than three decades of experience, has been named chief nursing officer at Northern Westchester Hospital (NWH).

“Catherine Manley-Cullen is a dynamic, progressive leader with a wide range of professional experience and a commitment to delivering compassionate care to culturally diverse populations,” says Derek Anderson, executive director of NWH. “She has devoted her career to enhancing patient safety, quality of care and supporting excellence in all facets of the professional practice. We are delighted to have her on board.”

Manley-Cullen brings NWH a broad range of experience in both academic and multi-specialty health care facilities. She specializes in clinical operations, patient care services, compliance and regulatory affairs, clinical management, performance improvement, and operational redesign. At NWH, she will support the continued development of high quality clinical services and oversee the nursing and professional care teams as well as the hospital’s Magnet designation program. She will collaborate with the Senior Leadership team to enhance and implement new programs. Manley-Cullen will continue to build on the already outstanding quality metrics at NWH with a focus on efficiencies that improve the overall patient & family experience.

Before joining NWH, Manley-Cullen was vice president patient care services/chief nursing officer NYU Langone Health-Brooklyn, leading daily clinical operations within the nursing departments. During her tenure at NYU Langone, Ms. Manley-Cullen helped plan and open the state-of-the-art Ronald O. Perelman Emergency Department, as well as the Cobble Hill Emergency Department in Brooklyn. She also implemented a behavioral health program in the emergency department that led to improved care and outcomes, and assisted in the development of an observation unit, a new care model that has reduced unnecessary admissions.

Ms. Manley-Cullen has widely presented on Care Transitions, specifically the development and implementation of a robust Emergency Department Follow-Up Program, Emergency Management Preparedness and quality and patient- experience initiatives. Her work in Nursing Sensitive Indicators led to an 85% reduction rate in catheter associated urinary tract infections, and a 65% decrease in central line associated blood stream infections. She also introduced SAFE programs across all system campuses to treat and support survivors of sexual assault. Her leadership contributed to the achievement of ACS Trauma certification and Joint Commission certifications in comprehensive stroke, stroke rehab, palliative care, and perinatal care.

Prior experience also includes the role of associate director at Mount Sinai’s Recanati/Miller Transplant Institute and a clinical manager at LiveOn New York. The gift of life through organ donation is one of her many passions. She also served as senior vice president and chief operating officer at Westchester Medical Center, where she held the additional roles of corporate compliance officer and assistant vice president of administration.

Manley-Cullen received a certificate for senior executives from Harvard University’s John F. Kennedy School of Government; a Master of Science degree from Pace University where she had a Michaelian Scholarship for Graduate Studies and a Bachelor of Science degree in nursing from the College of New Rochelle.

Manley-Cullen resides in Pleasantville, NY with her husband John, and has two daughters, Caitlin and Emily. She is a member of the American College of Healthcare Executives; Healthcare Leaders of New York; the American Nurses Association; the American Organization for Nursing Leadership; the Emergency Nurses Association; Sigma Theta Tau; and serves on the Advisory Board of Pace University.

About Northern Westchester Hospital

Northern Westchester Hospital (NWH), a member of Northwell Health, provides quality, patient-centered care that is close to home through a unique combination of medical expertise, leading-edge technology, and a commitment to humanity. Over 650 highly-skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment. NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA) National Hospital Quality Measures. Our high-quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For more information, please visit http://www.nwhc.net and connect with us on Facebook.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, about 750 outpatient facilities and more than 13,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 70,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Share article on social media or email:

Michael Best Strategies Acquires Bottom Line Marketing & Public Relations


We add expertise and depth, and we share a culture that values being inquisitive, proactive and street-smart.–Jeffrey Remsik

Michael Best Strategies (Strategies) today announced that it has acquired the Milwaukee-based strategic communications firm of Bottom Line Marketing & Public Relations, Inc. and added its owner Jeffrey J. Remsik to its growing team of seasoned professionals.

“Jeffrey and his team are a perfect fit for the type of strategic business consulting our clients need and want. We are excited to add such depth of expertise, especially in competitive intelligence, market research and marketing communications,” said Robert Marchant, president of Michael Best Strategies. “Jeffrey is comfortable in the C-suite and is a trusted advisor to numerous senior business leaders. He has built a solid business over the past two decades, and we are excited about adding him to our team.”

Marchant noted that besides Remsik, two Bottom Line public relations professionals will join the Strategies team, former reporter and experienced senior PR counselor Ron Irwin; and Margaret Fritsch, who brings with her expertise in media relations, strategic communications and public affairs.

“It’s a good match. We add expertise and depth, and we share a culture that values being inquisitive, proactive and street-smart,” said Remsik. “We are excited to join the impressive, professional team at Michael Best Strategies. We’re in a stronger position to help clients achieve their strategic business objectives.”

Remsik has specialized in serving clients in healthcare, financial services and real estate development. He joins a growing list of accomplished business executives and strategy professionals who have joined Strategies in the past three years.

About Michael Best Strategies

Michael Best Strategies is one of the nation’s fastest-growing B2B consulting firms specializing in government relations, public affairs, crisis management, shared value business planning, political partnership development and community/stakeholder engagement strategies. With offices in Washington, D.C., Chicago, Milwaukee, Madison, Waukesha, Austin, Denver, and Salt Lake City, we work with clients at the local, regional, and federal levels to advance their unique goals and objectives. Our industry expertise includes healthcare, agriculture, energy and environment, manufacturing, tax and finance, trade, higher education, and the food and beverage industry. Michael Best Strategies is affiliated with Michael Best & Friedrich, a full-service law firm with over 250 lawyers operating in 12 offices nationwide. For more information, visit michaelbeststrategies.com.

Share article on social media or email: